Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer.
about
Triptolide Inhibits the AR Signaling Pathway to Suppress the Proliferation of Enzalutamide Resistant Prostate Cancer Cells.High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancerUp regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer.Differential expression of the multidrug resistance 1 (MDR1) protein in prostate cancer cells is independent from anticancer drug treatment and Y box binding protein 1 (YB-1) activity.Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7.
P2860
Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Inhibition of RSK/YB-1 signali ...... zalutamide in prostate cancer.
@en
Inhibition of RSK/YB-1 signali ...... zalutamide in prostate cancer.
@nl
type
label
Inhibition of RSK/YB-1 signali ...... zalutamide in prostate cancer.
@en
Inhibition of RSK/YB-1 signali ...... zalutamide in prostate cancer.
@nl
prefLabel
Inhibition of RSK/YB-1 signali ...... zalutamide in prostate cancer.
@en
Inhibition of RSK/YB-1 signali ...... zalutamide in prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of RSK/YB-1 signali ...... nzalutamide in prostate cancer
@en
P2093
Akira Yokomizo
Ario Takeuchi
Eiji Kashiwagi
Junichi Inokuchi
Katsunori Tatsugami
Kenjiro Imada
Momoe Itsumi
Seiji Naito
Takeshi Uchiumi
P2860
P304
P356
10.1002/PROS.22813
P577
2014-04-17T00:00:00Z